Personalization of that intervention is based on gene-specific phenotypes; however, the age of ovarian cancer diagnosis in women with PVs in moderate penetrance ovarian cancer-risk genes is not well characterized. Women who had hereditary cancer panel testing from September 2013–May 2019 were ...
Patients and methods: For a 25-year period (1982-2006) 2016 patients with ovarian cancer were treated in our clinic. Results: 85 patients were 29 years of age or younger, 510 – from 30 to 49, 1229 patients – from 50 to 69 and 192 patients were older than 70 years of age. Most ...
in outcome between elderly (65 years of age) and younger (<65 years of age) women with epithelial ovarian cancer we examined the survival of patients with this malignancy who underwent their initial surgical evaluation at the Memorial Sloan-Kettering Cancer Center from January 1987-January 1991. ...
1,2-Diacetylbenzene (DAB) induces cognitive and motor deficits, which are the most common symptoms of cancer (e.g., glioma), and gene expression plays an important regulatory role during the progression of memory and motor deficits. We aimed to assess the expression patterns and molecular activ...
Age-specific differences in treatment and survival of ovarian cancer patients in the province of Limburg, the Netherlands, 1986–92. Int J Gynecol Cancer 1998; 8: 150–157.关键词:age ovarian cancer survival treatment DOI: 10.1046/j.1525-1438.1998.09746.x ...
A previous pan-cancer single cell analysis of ovarian, lung, and colorectal cancer, showed that COMP, COL10A1, COL11A1, and MMP1 all have higher expression in CAFs26. Our own analysis of that dataset showed that 19 of 20 matrix genes correlated appropriately with CAFs or non-CAFs. These...
Clin. Cancer Res. 24, 5098–5111 (2018). CAS PubMed PubMed Central Google Scholar Moore, K. N. et al. Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I. Ann. Oncol. 32, 757–...
Age at menarche (AAM) was found to be associated with ovarian cancer risk in previous observational studies. However, the causality of this association remains unclear. Here, after systematic meta‐analyses, we performed two‐sample Mendelian randomization (MR) analyses to evaluate the causal effect...
The outcome of treatment by age and socio-economic status was examined for 1,588 women with invasive cancer of cervix resident in the West of Scotland and ... RP Symonds,DW Lamont,MM Brodie,... 被引量: 0发表: 1993年 Specialist gynaecologists and survival outcome in ovarian cancer: a Scot...
The role of adjuvant ovarian suppression or ablation (OS/OA) in premenopausal women with hormone receptor-positive breast cancer remains controversial. The purpose of our study was to examine which patients might benefit from the addition of OS/OA to tamoxifen. We analyzed the data of 2065 premen...